Blar i forfatter "Gutteberg, Tore Jarl"

Viser treff 21-24 av 24

    • Redegjør for HPV-resultater 

      Sørbye, Sveinung Wergeland; Fismen, Silje; Gutteberg, Tore Jarl; Mortensen, Elin Synnøve (Chronicle; Kronikk, 2011-01-25)
      Fire Tromsø-leger tilbakeviser kritikk fra Bergen-professor om at de har oversolgt resultater fra sin studie om HPV-testing. De redegjør for hvordan de har fulgt opp kvinner med usikre celleforandringer.

    • Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study 

      Kileng, Hege; Gutteberg, Tore Jarl; Goll, Rasmus; Paulssen, Eyvind Jakob (Journal article; Tidsskriftartikkel; Peer reviewed, 2019-02-26)
      <i>Background - </i>Chronic hepatitis C virus (HCV) infection can progress to cirrhosis and end-stage liver disease in a substantial proportion of patients. The infection is frequently asymptomatic, leaving many infected individuals unaware of the diagnosis until complications occur. This advocates the screening of healthy individuals. The aim of this study was to estimate the prevalence of HCV ...

    • Triage of women with ASC-US/LSIL cytology: The added value of implementation of an HPV-test 

      Msomphora, Mbachi Ruth; Sørbye, Sveinung Wergeland; Gutteberg, Tore Jarl; Skjeldestad, Finn Egil (Conference object; Konferansebidrag, 2013)
      This study has an historical prospective design by including in retrospect all screening- and follow-up tests for women aged 25 to 69 years old kept by the Department of Clinical Pathology, University Hospital of Northern Norway, Tromsø. All women with a first ASC-US/LSIL smear in 1996-98 and 2006-08 were identified and compared on outcomes such as proportion of cases resolved within 35 months of ...

    • Triage of Women with Low-Grade Cervical Lesions : HPV mRNA Testing versus Repeat Cytology 

      Sørbye, Sveinung Wergeland; Arbyn, Marc; Fismen, Silje; Gutteberg, Tore Jarl; Mortensen, Elin (Journal article; Tidsskriftartikkel; Peer reviewed, 2011)
      In Norway, women with low-grade squamous intraepithelial lesions (LSIL) are followed up after six months in order to decide whether they should undergo further follow-up or be referred back to the screening interval of three years. A high specificity and positive predictive value (PPV) of the triage test is important to avoid unnecessary diagnostic and therapeutic procedures. At the University ...